JK BioPharma Solutions Inc 13D and 13G filings for NeuroBo Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-09-23 4:20 pm Sale |
2022-09-13 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO |
JK BioPharma Solutions Inc | 0 0.000% |
-10,908 (Position Closed) |
Filing |
| 2021-11-10 2:17 pm Unchanged |
2021-10-05 | 13D | NeuroBo Pharmaceuticals, Inc. NRBO |
JK BioPharma Solutions Inc | 10,908 9.800% |
0 (Unchanged) |
Filing |